| Patient | Mary Seacole |
|---|---|
| Date of birth | 1954-11-23 |
| Identifiers | MRN HR-NI027-SYN; SSN (made up) 000-27-4483 |
| Document date | 2026-05-11 |
| Author | Adwoa Fairweather-Kent, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Dizzy on standing for two days, with a cold. [S]
Mary Seacole, a 71-year-old woman with hypertension treated with amlodipine and chlorthalidone for eight weeks, came the same day because she has felt dizzy whenever she stands up for two days. She has had a head cold for four days, with a runny nose, a sore throat and little appetite, and has eaten mostly tea and toast. This morning, getting up from her chair, the room went grey and she caught the kitchen table; she did not fall, hit anything or lose consciousness. She has kept taking both blood pressure tablets, because she did not think a cold counted as being unable to eat; she has had no vomiting or diarrhea. She has no confusion, headache, chest pain, palpitations, weakness or numbness. She has not taken liquorice, which she paused at her first visit, or any cold remedies from the chemist. As a nurse she noticed her own pulse was fast and her mouth dry. [S]
| Element | Detail |
|---|---|
| Onset | Two days of dizziness on standing; cold for four days |
| Severity | Near-fall this morning; caught the table; no injury |
| Context | Little food for four days; still taking chlorthalidone and amlodipine |
| Associated signs and symptoms | Dry mouth, fast pulse; no confusion, vomiting, diarrhea, chest pain or neurological symptoms |
| Modifying factors | Better lying down or sitting |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; poor appetite; no fever over 38 C |
| Ears, nose, mouth, and throat | Positive | Runny nose and mild sore throat; dry mouth |
| Cardiovascular | Positive | Light-headed on standing; no chest pain or palpitations at rest |
| Neurological | Negative | No confusion, headache, weakness, numbness or speech change |
| Gastrointestinal | Negative | No vomiting or diarrhea |
| Respiratory | Negative | No breathlessness; slight cough |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day | 4 g to each knee up to four times a day | Topical route | 2026-03-09 | active | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-16 | active | S |
| Chlorthalidone 12.5 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 2026-03-16 to 2026-05-11 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-04-13 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-11 | Body height | 157 | cm | S |
| 2026-05-11 | Body weight | 77 | kg | S |
| 2026-05-11 | Body mass index (BMI) [Ratio] | 31.2 | kg/m2 | S |
| 2026-05-11 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-05-11 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-05-11 | Heart rate | 90 | /min | S |
| 2026-05-11 | Respiratory rate | 16 | /min | S |
| 2026-05-11 | Body temperature | 37.2 | Cel | S |
| 2026-05-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-11 | Sodium [Moles/volume] in Serum or Plasma | 129 | mmol/L | 135-145 mmol/L | Low | S |
| 2026-05-11 | Potassium [Moles/volume] in Serum or Plasma | 3.3 | mmol/L | 3.5-5.1 mmol/L | Low | S |
| 2026-05-11 | Creatinine [Mass/volume] in Serum or Plasma | 1.05 | mg/dL | 0.59-1.04 mg/dL | High | S |
| 2026-05-11 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 57 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 2026-05-11 | Glucose [Mass/volume] in Serum or Plasma | 102 | mg/dL | 70-99 mg/dL | High | S |
Vital signs recorded on 2026-05-11; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert, oriented and precise; mildly unwell; temperature 37.2 |
| Vital signs | Seated 118/70, pulse 90; lying 124/74, pulse 84; standing at one minute 98/60, pulse 106, with light-headedness, and at three minutes 102/62: orthostatic hypotension |
| Ears, nose and throat | Clear nasal discharge; mild throat redness; dry mucous membranes |
| Respiratory | Clear |
| Neurological | Oriented; no focal signs; no asterixis |
| Musculoskeletal | No injury from the near-fall |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Headaches on waking for three weeks and blood pressure 184/102 mmHg at the visit (average of two seated readings with a large cuff); no chest pain, breathlessness, visual loss, confusion or weakness; fundi with arteriolar narrowing but no hemorrhages or papilledema; no hypertensive emergency; hypertension not yet confirmed | resolved | provisional | R03.0 | S — Synthetic presenting problem; resolved into stage 2 hypertension when a week of home readings confirmed it. Not a claim about her real health. |
| Stage 2 hypertension confirmed by home readings (seven-day average 168/96 mmHg), with left ventricular hypertrophy by ECG voltage; no albuminuria; 10-year cardiovascular risk about 14%; treated to reduce the risk of stroke, heart failure and kidney disease | active | confirmed | I10 | S — Synthetic modern diagnosis made at the second visit. It is linked to the recorded apoplexy before her death only as the reason for the stroke-prevention teaching; the record does not claim that she had hypertension. |
| Bilateral primary knee osteoarthritis, worse on the left: pain on stairs and on rising from a chair, morning stiffness under 30 minutes, crepitus and bony enlargement without warmth; clinical diagnosis without imaging | active | confirmed | M17.0 | S — Synthetic modern problem; not a claim about her real health. |
| Fall risk: one fall in the past year, a trip on the outside steps without injury; afraid of falling and going out less; STEADI screen positive; Timed Up and Go 15 seconds | active | confirmed | Z91.81 | S — Synthetic fall-risk problem. |
| Obesity, class 1 (BMI 31.6); she calls herself stout and wants to lose some weight for her knees | active | confirmed | E66.811 | S — Synthetic modern problem; her self-description as stout is documented, her weight is not. |
| Thiazide-associated hyponatremia (sodium 129 mmol/L) and hypokalemia (potassium 3.3 mmol/L) with orthostatic hypotension and a near-fall, after four days of a cold with little food while taking chlorthalidone; no confusion; resolved after chlorthalidone was stopped | active | confirmed | E87.1 | S — Synthetic adverse drug event at an unscheduled visit; a common effect of thiazide diuretics in older women, not a historical diagnosis. |
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023)
Follow-up: Laboratory recheck in one week. Nurse telephone call in two days. Three-month review in five weeks. Next scheduled visit 2026-06-15: three-month review after chlorthalidone was stopped: blood pressure above target, losartan added; lipids on atorvastatin; knee and falls. [S]